According to the latest report by IMARC Group, titled "Bioanalytical Testing Services Market Report by Molecule Type (Small Molecule, Large Molecule), Test Type (ADME, PK, PD, Bioavailability, Bioequivalence, and Others), Workflow (Sample Preparation, Sample Analysis, and Others), and Region 2025-2033," the global bioanalytical testing services market reached a value of USD 3.4 Billion in 2024. Bioanalytical testing services are generally utilized by laboratory professionals for determining the drug concentration in biological fluids. Some of the commonly adopted services include ligand binding assays and hyphenated and chromatographic techniques that assist in analyzing the metabolites, detecting pharmacodynamic biomarkers, and analytes in complex biological matrices, such as blood, stool, urine, plasma, cell lysates, plasma, breast milk, cerebrospinal fluid (CSF), tissue homogenates, and serum. As a result, these services are extensively used in the production of medicines and for clinical and preclinical bioanalysis.
Global Bioanalytical Testing Services Market Trends:
The global market is primarily driven by significant growth in the pharmaceutical industry. Along with this, the increasing prevalence of infectious diseases among the masses is providing an impetus to the market growth across the globe. In line with this, the escalating need for personalized medical treatments and point-of-care (POC) diagnostic services for individuals is providing a boost to the market growth. Furthermore, the sudden outbreak of coronavirus disease (COVID-19) has propelled the demand for bioanalytical testing services. This, along with the rising utilization of testing services in the manufacturing of generic drugs is creating a positive outlook for the market. Additionally, various technological advancements, such as the widespread adoption of robotics for sample preparation and increasing investments by public and private firms to upgrade the existing pharmaceutical infrastructure are acting as major growth-inducing factors. Other factors, including continual improvements in the healthcare industry and extensive research and development (R&D) activities conducted by key players, are contributing to the market growth. Looking forward, IMARC Group expects the market value to reach USD 7.4 Billion by 2033, exhibiting a CAGR of 8.54% during 2025-2033.
Market Summary:
Report Scope:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Molecule Type, Test Type, Workflow, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Almac Group, Charles River Laboratories International Inc., Frontage Laboratories Inc., ICON plc, Intertek Group plc, Laboratory Corporation of America Holdings, Pace Analytical Services LLC, PPD Inc., PRA Health Sciences, SGS SA, Syneos Health and Toxikon Corporation |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800